Covance Inc. - Strategic SWOT Analysis Review

  • ID: 3666471
  • SWOT Analysis
  • 41 pages
  • GlobalData
  • Covance Inc.
1 of 5

FEATURED COMPANIES

  • Gemmus Pharma Inc.
  • ICON Plc
  • MPI Research Inc
  • MORE
Covance Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Covance Inc. (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. It also offers services including laboratory testing for agrochemical, chemical and food industries. The early-stage development services that the company offers include preclinical and clinical pharmacology services and discovery support services. Its late-stage development services include Phase II-IV clinical development, central laboratory and market access services. The company operates across the US, Europe, South America and Asia-Pacific. Covance is headquartered in Princeton, New Jersey, the US.

Covance Inc. Key Recent Developments

Mar 14, 2016: Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials
Sep 21, 2015: Covance to Open Second Current Good Manufacturing Practice Pharmacy in U.S.
Aug 24, 2015: Covance Announces Pioneering Agreement with Leading Pharmaceutical Company for Worldwide Portfolio-Level Clinical Trial Monitoring
Feb 04, 2015: Covance Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million
Jan 20, 2015: Covance Launches New Solution to Bridge Preclinical to Clinical Development

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Gemmus Pharma Inc.
  • ICON Plc
  • MPI Research Inc
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Covance Inc. - Key Facts

Covance Inc. - Key Employees

Covance Inc. - Key Employee Biographies

Covance Inc. - Key Operational Employees

Covance Inc. - Major Products and Services

Covance Inc. - History

Covance Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Covance Inc. - Business Description

Covance Inc. - Corporate Strategy

Covance Inc. - SWOT Analysis

SWOT Analysis - Overview

Covance Inc. - Strengths

Strength - Specialized Services

Strength - Operational Network

Strength - Xcellerate Monitoring Sets New Standards

Covance Inc. - Weaknesses

Weakness - Clinical Trial Delays

Covance Inc. - Opportunities

Opportunity - Business Initiatives

Opportunity - Agreements and Collaborations

Opportunity - Growth Prospects: Pharmaceutical Outsourcing

Covance Inc. - Threats

Threat - Competitive Pressures

Threat - Technological Changes

Threat - Stringent Regulations

Covance Inc. - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Covance Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Covance Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016

Covance Inc., Recent Deals Summary

Section 4 – Company’s Recent Developments

Mar 14, 2016: Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials

Sep 21, 2015: Covance to Open Second Current Good Manufacturing Practice Pharmacy in U.S.

Aug 24, 2015: Covance Announces Pioneering Agreement with Leading Pharmaceutical Company for Worldwide Portfolio-Level Clinical Trial Monitoring

Feb 04, 2015: Covance Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million

Jan 20, 2015: Covance Launches New Solution to Bridge Preclinical to Clinical Development

Section 5 – Appendix

Methodology

About us

Contact Us

Disclaimer

List of Tables

Covance Inc., Key Facts

Covance Inc., Key Employees

Covance Inc., Key Employee Biographies

Covance Inc., Key Operational Employees

Covance Inc., Major Products and Services

Covance Inc., History

Covance Inc., Other Locations

Covance Inc., Subsidiaries

Covance Inc., Key Competitors

Covance Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Covance Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016

Covance Inc., Recent Deals Summary

List of Figures

Covance Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Covance Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Covance Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
WIL Research Company, Inc.
Quintiles Transnational Holdings Inc.
Quest Diagnostics Incorporated
Parexel International Corporation
MPI Research Inc
ICON Plc
Gemmus Pharma Inc.
Charles River Laboratories International, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll